The founders of Lovable and Builder.ai individually received more funds than the whole group of the researchers behind this medicine...
I hope they can get this to people quickly. Someone I love has been diagnosed with stage 3 end of Feb this year and it's utter hell. For everyone, not just the patient.
While not fully approved, the company has early access available to people who meet the treatment criteria and would potentially benefit. Their HCP should evaluate this (it's not all types of pancreatic cancer, and it's not a silver bullet - but it looks like its double the survival time than current chemo). Hopefully this evolves into a new class of treatment.
Derek Lowe’s writeup is good: https://www.science.org/content/blog-post/progress-against-p...
Totally naive question: is this a situation where stacking the drug with chemo might be even better?
If you want to see what the side effects look like, look at ex Senator Ben Sasse: https://youtu.be/7CFo6-6BN9k?si=2B3dqB4rOhAnPiZl
Paper: https://www.nejm.org/doi/full/10.1056/NEJMoa2605555?query=fe...
The founders of Lovable and Builder.ai individually received more funds than the whole group of the researchers behind this medicine...
I hope they can get this to people quickly. Someone I love has been diagnosed with stage 3 end of Feb this year and it's utter hell. For everyone, not just the patient.
While not fully approved, the company has early access available to people who meet the treatment criteria and would potentially benefit. Their HCP should evaluate this (it's not all types of pancreatic cancer, and it's not a silver bullet - but it looks like its double the survival time than current chemo). Hopefully this evolves into a new class of treatment.
Source article for those interested:
https://www.nejm.org/doi/full/10.1056/NEJMoa2505783
Paywalled but has a free access option if you make an account.